TrialCNS drugs2019

Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.

James W Wheless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.